Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Astellas has announced its acquisition of Xyphos for $665m

europeanpharmaceuticalreviewJanuary 09, 2020

Tag: Astellas , Xyphos , acquisition

PharmaSources Customer Service